A new diagnostic method that ascertains if a person is suffering from Parkinson’s disease or dementia by looking at the manner of walking has been patented.
A new diagnostic technique developed by a St. Mary's Hospital research team in Uijeongbu has been patented and put up for patent registration, which analyses data from an individual's shoes to detect neurological disorders.
Most degenerative brain disorders, such as Parkinson's disease, dementia, and Lou Gehrig's disease, occur at an older age.
Currently, a costly MRI or a PET scan is required for such diagnosis, as well as frequent visits to the hospital.
The new approach, on the other hand, employs a "smart insole" that is placed inside a shoe and collects data from its sensors, which is then analyzed to assess the brain health of the wearer.
The new technique achieved an accuracy of 98.1 percent for the diagnosis of Parkinson's disease, as well as 83.2 percent for differentiating whether an illness is vascular or degenerative.


Gold Prices Hold Firm as Traders Watch U.S.-Iran Ceasefire and Trump-Xi Talks
Medicare to Cover GLP-1 Weight-Loss and Diabetes Drugs Starting July 1
Moderna to Pay Up to $2.25B to Settle LNP Patent Dispute Over COVID-19 Vaccine Technology
Trump Rejects Iran Proposal as Strait of Hormuz Crisis Pushes Oil Prices Higher
US Stock Futures Hold Steady Ahead of CPI Data and Iran Conflict Concerns
Trump Administration Seeks Court Pause to Reinstate 10% Global Tariffs
South Korea Central Bank Signals Inflation Concerns as Oil Prices Surge
Senate Sets December 8 Vote on Trump’s NASA Nominee Jared Isaacman
Novo Nordisk Raises 2026 Outlook on Strong Wegovy Demand
Is dark chocolate healthier than milk chocolate? 2 dietitians explain
Astronomers have discovered another puzzling interstellar object − this third one is big, bright and fast
Moderna Stock Drops After FDA Declines Review of mRNA Flu Vaccine
China vs. NASA: The New Moon Race and What's at Stake by 2030
Eli Lilly’s Inluriyo Gains FDA Approval for Advanced Breast Cancer Treatment
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning 



